“The FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines”, says Peter Doshi.
| Refresh | This website www.canadiancovidcarealliance.org/fr/media/does-the-fda-think-these-data-justify-the-first-full-approval-of-a-covid-19-vaccine/ is currently offline. Cloudflare's Always Online™ shows a snapshot of this web page from the Internet Archive's Wayback Machine. To check for the live version, click Refresh. |
“The FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines”, says Peter Doshi.
